Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy

Journal of the Neurological Sciences

Volumn 267, Issue 1-2, 2008, Pages 48-56

  Sun, Guilian ^a,b   Haginoya, Kazuhiro ^a,d   Wu, Yanling ^a   Chiba, Yoko ^a   Nakanishi, Tohru ^c   Onuma, Akira ^d   Sato, Yuko ^e   Takigawa, Masaharu ^f   Iinuma, Kazuie ^a   Tsuchiya, Shigeru ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c SHUJITSU UNIVERSITY   (Japan)

^d Takuto Rehabilitation Center for Children   (Japan)

^e Sophia Yuko Ladies Clinic   (Japan)

^f OKAYAMA UNIVERSITY   (Japan)

Author keywords

Connective tissue growth factor; Fibrosis; Immunohistochemistry; Muscular dystrophy; RT PCR; Transforming growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA;

ANTIBODY LABELING; ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FLUORESCENCE MICROSCOPY; GAIT; GENE SEQUENCE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; IMMUNOREACTIVITY; MALE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; MYOFIBROSIS; NEUROMUSCULAR SYNAPSE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYMPTOM;

ADOLESCENT; BASEMENT MEMBRANE; BIOLOGICAL MARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CONNECTIVE TISSUE; FEMALE; FIBROBLASTS; FIBROSIS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INFANT; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PARACRINE COMMUNICATION; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 39049164607     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2007.09.043     Document Type: Article

References (47)

1. Hoffman E.P., Brown R.H.J., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell Growth Differ 51 (1987) 919-928
2. Endo T., and Toda T. Glycosylation in congenital muscular dystrophies. Biol Pharm Bull 26 (2003) 1641-1647
3. Partridge T.A. Animal models of muscular dystrophy-what can they teach us?. Neuropathol Appl Neurobiol 17 (1991) 353-363
4. Porter J.D. Commentary: extraocular muscle sparing in muscular dystrophy: a critical evaluation of potential protective mechanisms. Neuromuscul Disord 8 (1998) 189-203
5. Chen Y.W., Nagaraju K., Bakay M., McIntyre O., Rawat R., Shi R., et al. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology 65 (2005) 826-834
6. Sander M., Chavoshan B., Harris S.A., Iannaccone S.T., Stull J.T., Thomas G.D., et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 97 (2000) 13818-13823
7. Bernasconi P., Torchiana E., Confalonieri P., Brugnoni R., Barresi R., Mora M., et al. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 96 (1995) 1137-1144
8. Leask A., and Abraham D.J. TGF-beta signaling and the fibrotic response. FASEB J 18 (2004) 816-827
9. Ishitobi M., Haginoya K., Zhao Y., Ohnuma A., Minato J., Yanagisawa T., et al. Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy. NeuroReport 11 (2000) 4033-4035
10. Igarashi A., Okochi H., Bradham D.M., and Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4 (1993) 637-645
11. Igarashi A., Nashiro K., Kikuchi K., Sato S., Ihn H., Grotendorst G.R., et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 105 (1995) 280-284
12. Bradham D.M., Igarashi A., Potter R.L., and Grotendorst G.R. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114 (1991) 1285-1294
13. Ihn H. Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 14 (2002) 681-685
14. Ryseck R.P., Macdonald-Bravo H., Mattei M.G., and Bravo R. Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ 2 (1991) 225-233
15. Frazier K., Williams S., Kothapalli D., Klapper H., and Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107 (1996) 404-411
16. Passerini L., Bernasconi P., Baggi F., Baggi F., Confalonieri P., Cozzi F., et al. Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy. Neuromuscul Disord 12 (2002) 828-835
17. Shimo T., Nakanishi T., Kimura Y., Nishida T., Ishizeki K., Matsumura T., et al. Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells. J Biochem (Tokyo) 124 (1998) 130-140
18. Kondo Y., Nakanishi T., Takigawa M., and Ogawa N. Immunohistochemical localization of connective tissue growth factor in the rat central nervous system. Brain Res 834 (1999) 146-151
19. Sundberg C., Ivarsson M., Gerdin B., and Rubin K. Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 74 (1996) 452-466
20. Zhao Y., Haginoya K., Sun G., Dai H., Onuma A., and Iinuma K. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study. J Pathol 201 (2003) 149-159
21. D'Amore P.A., Brown R.H.J., Ku P.T., Hoffman E.P., Watanabe H., Arahata K., et al. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol 35 (1994) 362-365
22. Sander M., Chavoshan B., Harris S.A., Iannaccone S.T., Stull J.T., Thomas G.D., et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci U S A 97 (2000) 13818-13823
23. Rodriguez M.C., and Tarnopolsky M.A. Patients with dystrophinopathy show evidence of increased oxidative stress. Free Radic Biol Med 34 (2003) 1217-1220
24. Spencer M.J., and Tidball J.G. Do immune cells promote the pathology of dystrophin-deficient myopathies?. Neuromuscul Disord 11 (2001) 556-564
25. Gorospe J.R., Tharp M.D., Hinckley J., Kornegay J.N., and Hoffman E.P. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J Neurol Sci 122 (1994) 44-56
26. Lindahl M., Backman E., Henriksson K.G., Gorospe J.R., and Hoffman E.P. Phospholipase A2 activity in dystrophinopathies. Neuromuscul Disord 5 (1995) 193-199
27. Rodriguez-Barbero A., Obreo J., Yuste L., Montero J.C., Rodriguez-Pena A., Pandiella A., et al. Transforming growth factor-beta1 induces collagen synthesis and accumulation via p38 mitogen-activated protein kinase (MAPK) pathway in cultured L(6)E(9) myoblasts. FEBS Lett 513 (2002) 282-288
28. Li Y., Foster W., Deasy B.M., Chan Y., Prisk V., Tang Y., et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis. Am J Pathol 164 (2004) 1007-1019
29. Takehara K. Growth regulation of skin fibroblasts. J Dermatol Sci 24 Suppl 1 (2000) S70-S77
30. Raju R., and Dalalkas M.C. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain 128 (2005) 1887-1896
31. Ricupero D.A., Rishikof D.C., Kuang P.P., Poliks C.F., and Goldstein R.H. Regulation of connective tissue growth factor expression by prostaglandin E(2). Am J Physiol 277 (1999) L1165-L1171
32. Chambers R.C., Leoni P., Blanc-Brude O.P., Wembridge D.E., and Laurent G.J. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 275 (2000) 35584-35591
33. Suzuma K., Naruse K., Suzuma I., Takahara N., Ueki K., Aiello L.P., et al. Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem 275 (2000) 40725-40731
34. Ruperez M., Lorenzo O., Blanco-Colio L.M., Esteban V., Egido J., and Ruiz-Ortega M. Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis. Circulation 108 (2003) 1499-1505
35. Pereira R.C., Durant D., and Canalis E. Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. Am J Physiol Endocrinol Metab 279 (2000) E570-E576
36. Obreo J., Diez-Marques L., Lamas S., Duwell A., Eleno N., Bernabeu C., et al. Endoglin expression regulates basal and TGF-beta1-induced extracellular matrix synthesis in cultured L6E9 myoblasts. Cell Physiol Biochem 14 (2004) 301-310
37. Maeda N., Kanda F., Okuda S., Ishihara H., and Chihara K. Transforming growth factor beta enhances conective tissue growth factor expression in L6 rat myotubes. Neuromuscul Disord 15 (2005) 790-793
38. Seale P., Polasskaya A., and Rudnicki M.A. Adult stem cell specification by Wnt signaling in muscle regeneration. Cell Cycle 2 (2003) 418-419
39. Mercurio S., Latinkic B., Itasaki N., Krumlauf R., and Smith J.C. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131 (2003) 2137-2147
40. Croci S., Landuzzi L., Astolfi A., Nicoletti G., Rosolen A., Sartori F., et al. Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells. Cancer Res 64 (2004) 1730-1736
41. Moscoso L.M., Cremer H., and Sanes J.R. Organization and reorganization of neuromuscular junctions in mice lacking neural cell adhesion molecule, tenascin-C, or fibroblast growth factor-5. J Neurosci 18 (1998) 1465-1477
42. McLennan I.S., and Koishi K. Transforming growth factor-beta-2 (TGF-beta 2) is associated with mature rat neuromuscular junctions. Neurosci Lett 177 (1994) 151-154
43. Zhao Y., Haginoya K., and Iinuma K. Strong immunoreactivity of platelet-derived growth factor and its receptor at human and mouse neuromuscular junctions. Tohoku J Exp Med 189 (1999) 239-244
44. Luo Z., Wang Q., Dobbins C., Levy S., Xiong W.C., and Mei L. Signaling complexes for postsynaptic differentiation. J Neurocytol 32 (2003) 697-708
45. Magnusson C., Svensson A., Christerson U., and Tagerud S. Denervation-induced alterations in gene expression in mouse skeletal muscle. Eur J Neurosci 21 (2005) 577-580
46. Murakami N., McLennan I.S., Nonaka I., Koishi K., Baker C., and Hammond-Tooke G. Transforming growth factor-beta2 is elevated in skeletal muscle disorders. Muscle Nerve 22 (1999) 889-898
47. Yokoi H., Mukoyama M., Nagae T., Mori K., Suganami T., Sawai K., et al. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc Nephrol 15 (2004) 1430-1440